PAS
ELV icon

Park Avenue Securities’s Elevance Health ELV Stock Holding History

Park Avenue Securities’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.28M Sell
11,054
-892
-7% -$331K 0.03% 420
2026
Q1 		$3.5M Buy
11,946
+614
+5% +$202K 0.03% 404
2025
Q4 		$3.97M Buy
11,332
+1,121
+11% +$379K 0.03% 346
2025
Q3 		$3.3M Buy
10,211
+1,503
+17% +$467K 0.03% 422
2025
Q2 		$3.39M Sell
8,708
-1,241
-12% -$499K 0.03% 356
2025
Q1 		$4.33M Buy
9,949
+3,249
+48% +$1.3M 0.05% 224
2024
Q4 		$2.47M Sell
6,700
-2,602
-28% -$1.09M 0.03% 396
2024
Q3 		$4.84M Buy
9,302
+164
+2% +$87.6K 0.05% 226
2024
Q2 		$4.95M Buy
9,138
+646
+8% +$341K 0.06% 212
2024
Q1 		$4.4M Buy
8,492
+882
+12% +$439K 0.06% 222
2023
Q4 		$3.59M Buy
7,610
+74
+1% +$34.2K 0.05% 225
2023
Q3 		$3.28M Buy
+7,536
New +$3.42M 0.05% 230
2023
Q1 		– Sell
-6,000
Closed -$3.08M – 834
2022
Q4 		$3.08M Buy
6,000
+1,443
+32% +$733K 0.05% 211
2022
Q3 		$2.07M Buy
4,557
+539
+13% +$258K 0.04% 260
2022
Q2 		$1.94M Sell
4,018
-792
-16% -$392K 0.04% 274
2022
Q1 		$2.36M Buy
4,810
+439
+10% +$201K 0.04% 246
2021
Q4 		$2.03M Buy
4,371
+121
+3% +$50.9K 0.04% 277
2021
Q3 		$1.58M Buy
4,250
+490
+13% +$186K 0.03% 286
2021
Q2 		$1.44M Sell
3,760
-507
-12% -$194K 0.03% 289
2021
Q1 		$1.53M Buy
4,267
+33
+0.8% +$10.6K 0.04% 245
2020
Q4 		$1.36M Buy
4,234
+476
+13% +$146K 0.04% 222
2020
Q3 		$1.01M Buy
3,758
+312
+9% +$84K 0.03% 232
2020
Q2 		$906K Buy
3,446
+799
+30% +$213K 0.03% 206
2020
Q1 		$601K Buy
2,647
+332
+14% +$90.5K 0.05% 118
2019
Q4 		$699K Buy
2,315
+295
+15% +$81.2K 0.03% 237
2019
Q3 		$485K Buy
2,020
+247
+14% +$67.7K 0.02% 254
2019
Q2 		$500K Buy
1,773
+231
+15% +$63.1K 0.06% 129
2019
Q1 		$445K Buy
+1,542
New +$446K 0.02% 238

Other funds holding ELV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Park Avenue Securities's ELV Position: Q2 2026 in Review

Park Avenue Securities reduced its Elevance Health (ELV) stake by 7.5% in Q2 2026, selling an estimated $331K and leaving 11,054 shares worth $4.28M. The position accounts for 0.03% of the portfolio, ranked #420.

Park Avenue Securities first reported a position in ELV in Q1 2019 and has held it in 28 quarters since. The position peaked at $4.95M in Q2 2024. 417 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Park Avenue Securities held 11,054 shares of Elevance Health worth $4.28M as of Q2 2026.
  • Park Avenue Securities sold 892 Elevance Health shares in Q2 2026, an estimated $331K.
  • Elevance Health made up 0.03% of Park Avenue Securities's portfolio in Q2 2026, its #420 holding.
  • Park Avenue Securities first reported a position in Elevance Health in Q1 2019 and has held it in 28 quarters since.
  • Park Avenue Securities's Elevance Health position peaked at $4.95M in Q2 2024.
  • 417 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.